Amgen(CH:AMG)
CHFÂ 380.320.00 (0.00%)
CH:AMG
Amgen stock forecast
CHFÂ 380.32
At close:0.00 (0.00%)
Amgen (AMG) Stock Forecast & Price Target
1 Followers
AMG Analyst Ratings
Moderate Buy
9Buy17Hold1Sell
Based on 27 analysts giving stock ratings to Amgen in the past 3 months
AMG Stock 12 Month Forecast
Average Price Target
CHF376.08â–¼(-1.12% Downside)Based on 27 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is CHF 376.08 with a high forecast of CHF 446.09 and a low forecast of CHF 288.79. The average price target represents a -1.12% change from the last price of CHF 380.32.
Past 12 Months12 Month ForecastJan2026Oct2026
HighCHF446.09
AverageCHF376.08
LowCHF288.79
Highest Price TargetHighestCHF446.09Average Price TargetCHF376.08Lowest Price TargetLowestCHF288.79
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Terence Flynn | Morgan Stanley | CHF341.22 | hold | -10.28%Downside | Reiterated | 11/12/26 | ||
| Gary Nachman | Canaccord Genuity | CHF366.19 | hold | -3.71%Downside | Reiterated | 11/12/26 | ||
| Jasper Hellweg | Argus Research | CHF382.84→CHF428.61 | buy | 12.70%Upside | Reiterated | 11/12/26 | ||
| David Amsellem | Piper Sandler | CHF380.34 | buy | <0.01%Upside | Reiterated | 11/09/26 | ||
| Mohit Bansal | Wells Fargo | CHF382.84 | hold | 0.66%Upside | Reiterated | 11/08/26 | ||
| Ilya Zubkov | Freedom Capital Markets | CHF374.51→CHF391.16 | hold | 2.85%Upside | Downgraded | 11/06/26 | ||
| Geoff Meacham | Citi | CHF337.06→CHF387.00 | hold | 1.76%Upside | Reiterated | 11/05/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | CHF328.74→CHF386.16 | hold | 1.54%Upside | Reiterated | 11/05/26 | ||
| Salveen Richter | Goldman Sachs | CHF400.31→CHF446.09 | buy | 17.29%Upside | Reiterated | 11/04/26 | ||
| Tazeen Ahmad | Bank of America Securities | CHF272.98→CHF288.79 | sell | -24.07%Downside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | CHF357.87→CHF391.16 | buy | 2.85%Upside | Assigned | 11/04/26 | ||
| Chris Schott | J.P. Morgan | CHF291.29→CHF353.71 | hold | -7.00%Downside | Reiterated | 11/04/26 | ||
| Courtney Breen | Bernstein | CHF287.13→CHF332.90 | hold | -12.47%Downside | Assigned | 11/04/26 | ||
| Evan Seigerman | BMO Capital | CHF345.38→CHF367.85 | hold | -3.28%Downside | Reiterated | 11/04/26 | ||
| Louise Chen | Scotiabank | CHF416.13→CHF441.09 | buy | 15.98%Upside | Reiterated | 11/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Terence FlynnMorgan Stanley | HoldReiteratedCHF341.22 | 11/12/26 | -10.28%Downside | ||
| Gary NachmanCanaccord Genuity | HoldReiteratedCHF366.19 | 11/12/26 | -3.71%Downside | ||
| Jasper HellwegArgus Research | BuyReiteratedCHF382.84→CHF428.61 | 11/12/26 | 12.70%Upside | ||
| David AmsellemPiper Sandler | BuyReiteratedCHF380.34 | 11/09/26 | <0.01%Upside | ||
| Mohit BansalWells Fargo | HoldReiteratedCHF382.84 | 11/08/26 | 0.66%Upside | ||
| Ilya ZubkovFreedom Capital Markets | HoldDowngradedCHF374.51→CHF391.16 | 11/06/26 | 2.85%Upside | ||
| Geoff MeachamCiti | HoldReiteratedCHF337.06→CHF387.00 | 11/05/26 | 1.76%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | HoldReiteratedCHF328.74→CHF386.16 | 11/05/26 | 1.54%Upside | ||
| Salveen RichterGoldman Sachs | BuyReiteratedCHF400.31→CHF446.09 | 11/04/26 | 17.29%Upside | ||
| Tazeen AhmadBank of America Securities | SellReiteratedCHF272.98→CHF288.79 | 11/04/26 | -24.07%Downside | ||
| Luca IssiRBC Capital | BuyAssignedCHF357.87→CHF391.16 | 11/04/26 | 2.85%Upside | ||
| Chris SchottJ.P. Morgan | HoldReiteratedCHF291.29→CHF353.71 | 11/04/26 | -7.00%Downside | ||
| Courtney BreenBernstein | HoldAssignedCHF287.13→CHF332.90 | 11/04/26 | -12.47%Downside | ||
| Evan SeigermanBMO Capital | HoldReiteratedCHF345.38→CHF367.85 | 11/04/26 | -3.28%Downside | ||
| Louise ChenScotiabank | BuyReiteratedCHF416.13→CHF441.09 | 11/04/26 | 15.98%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Amgen
3 Months
Success Rate16/22 ratings generated profit
73%
Average Return
+6.98%
Copying David Amsellem's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +6.98% per trade.
1 Year
Success Rate21/22 ratings generated profit
95%
Average Return
+29.66%
Copying David Amsellem's trades and holding each position for 1 Year would result in 95.45% of your transactions generating a profit, with an average return of +29.66% per trade.
2 Years
Success Rate29/30 ratings generated profit
97%
Average Return
+30.55%
Copying Jay Olson's trades and holding each position for 2 Years would result in 96.67% of your transactions generating a profit, with an average return of +30.55% per trade.
AMG Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 19 | 24 | 34 | 41 | 35 |
| Hold | 22 | 26 | 39 | 47 | 48 |
| Sell | 2 | 3 | 5 | 6 | 5 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 43 | 53 | 78 | 94 | 88 |
In the current month, AMG has received 35 Buy Ratings, 48 Hold Ratings, and 5 Sell Ratings. AMG average Analyst price target in the past 3 months is 376.08.
AMG Financial Forecast
HighCHF5.08
ConsensusCHF4.71
LowCHF4.29
AMG Earnings Forecast
Next quarter’s earnings estimate for AMG is CHF 4.71 with a range of CHF 4.29 to CHF 5.08. The previous quarter’s EPS was CHF 5.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF8.99B
ConsensusCHF8.73B
LowCHF8.51B
AMG Sales Forecast
Next quarter’s sales forecast for AMG is CHF 8.73B with a range of CHF 8.51B to CHF 8.99B. The previous quarter’s sales results were CHF 8.65B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
AMG Stock Forecast FAQ
What is CH:AMG’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is CHF376.08.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amgen a Buy, Sell or Hold?
Amgen has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 17 hold ratings and 1 sell ratings.
What is Amgen’s share price target?
The average share price target for Amgen is CHF376.08. This is based on 27 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF446.09, and the lowest forecast is CHF288.79. The average share price target represents a 1.12% decrease from the current price of CHF380.318.
What do analysts say about Amgen?
Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Street analysts.
How can I buy shares of Amgen?
To buy shares of CH:AMG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
